Payors Using Clinical Pathways
During the 2016 American Society of Hematology (ASH) meeting, I was interviewed by OBR to offer an opinion on how payers are implementing clinical pathways in how they provide coverage to patients with hematologic malignancies. Pathways are not always welcome by physicians and healthcare providers and there is always a debate about their value. In